NOVAVAX INC

NVAX - Company ID 0001000694

Market cap$1.55 B

Rank#2337

Filings1,627

NOVAVAX INC has filed 1,627 public company documents between 1996 and 2026. The most frequent type is insider trade (669 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchNVAX overview$1.55 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2337See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut NVAX beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow NVAX via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
EFFECT	EFFECT	6y ago2020-01-09	-	View filing
EFFECT	EFFECT	8y ago2018-01-12	-	View filing
EFFECT	EFFECT	9y ago2017-01-19	-	View filing
EFFECT	EFFECT	13y ago2013-07-08	-	View filing
EFFECT	EFFECT	13y ago2013-05-02	-	View filing
EFFECT	EFFECT	16y ago2010-04-27	-	View filing
EFFECT	EFFECT	19y ago2006-12-11	-	View filing

NOVAVAX INC

Similar companies to research next

Year